Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

ESSA Pharma Inc. Common Stock (EPIX)

Pharmaceutical Preparations

https://www.essapharma.com

ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.

SUITE 720, 999 WEST BROADWAY
VANCOUVER, A1

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/12/2015

Market Cap

204,984,586

Shares Outstanding

44,140,000

Weighted SO

44,142,088

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

CYTO --.--%

SMMT --.--%

ATXI --.--%

SPRO --.--%

AGLE --.--%

Beta

1.8260

Last Div

0.0000

Range

2.58-11.67

Chg

-0.1500

Avg Vol

49267

Mkt Cap

204984586

Exch

NASDAQ

Country

CA

Phone

17783310962

DCF Diff

3.7885

DCF

0.7626

Div Yield

0.0000

P/S

0.0000

EV Multiple

-3.7161

P/FV

1.5906

Div Yield %

0.0000

P/E

-7.4079

PEG

-0.2963

Payout

0.0000

Current Ratio

36.9480

Quick Ratio

36.9480

Cash Ratio

24.0514

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

7328.8732

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.0007

ROA

-0.2086

ROE

-0.2017

ROCE

-0.2323

NI/EBT

1.0000

EBT/EBIT

0.9227

EBIT/Rev

0.0000

Debt Ratio

0.0026

D/E

0.0027

LT Debt/Cap

0.0018

Total Debt/Cap

0.0026

Int Coverage

-26748.7841

CF/Debt

-69.2969

Equity Multi

1.0295

Rec Turnover

0.0000

Pay Turnover

0.0498

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-0.5344

FCF/Share

-0.5344

Cash/Share

2.9459

OCF/Sales

0.0000

FCF/OCF

1.0000

CF Coverage

-69.2969

ST Coverage

-210.8718

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

1.5906

P/B

1.5906

P/S

0.0000

P/E

-7.4079

P/FCF

-8.6457

P/OCF

-8.6450

P/CF

-8.6450

PEG

-0.2963

P/S

0.0000

EV Multiple

-3.7161

P/FV

1.5906

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Mar 12, 02:27 ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX GlobeNewswire Inc. Mar 07, 00:24 ?????? ROSEN ?? ESSA Pharma Inc. ????? EPIX ???????????????????? GlobeNewswire Inc. Feb 17, 23:17 ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX GlobeNewswire Inc. Feb 14, 22:33 EPIX STOCK NEWS: EPIX Shareholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Lawsuit Against Essa Pharma Inc. GlobeNewswire Inc. Feb 08, 17:42 ROSEN, A TOP RANKED LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX GlobeNewswire Inc. Jan 31, 23:27 ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX

Revenue Product Segmentation